Search filters

List of works by David D Stenehjem

A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysis.

scientific article published on 3 September 2013

Adaptive trial design: Its growing role in clinical research and implications for pharmacists

scientific article published on May 1, 2011

Adherence to Oral Medications During Maintenance Therapy Among Children and Adolescents With Acute Lymphoblastic Leukemia: A Medication Refill Analysis.

scientific article published in November 2017

Aspirin and Cancer Risk.

scientific article

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer

scientific article

BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort study.

scientific article published on 22 March 2016

Ceritinib: A primer for pharmacists.

scientific article

Characterization and survival of patients with metastatic basal cell carcinoma in the Department of Veterans Affairs: a retrospective electronic health record review

scientific article published on 08 May 2018

Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy

scientific article published on 22 June 2020

Clinical and economic analysis of patients with acute myeloid leukemia by FLT3 status and midostaurin use at a Comprehensive Cancer Center

scientific article published on 24 October 2019

Comparative efficacy and safety of interventions for preventing chemotherapy-induced oral mucositis in adult cancer patients: a systematic review and network meta-analysis

scientific article published on 16 November 2018

Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2.

scientific article published on 29 September 2016

Correlation of degree of hypothyroidism with survival outcomes in patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors.

scientific article published on 15 November 2014

Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer

scientific article published on 27 November 2015

Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia

scientific article published on 13 November 2014

Diagnosis and treatment of cancer-related anemia.

scientific article published on February 2014

Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports

scientific article published on 22 January 2018

Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor receptor inhibitors

scientific article published on January 2017

Efficacy of Eplerenone in the Management of Mineralocorticoid Excess in Men With Metastatic Castration-resistant Prostate Cancer Treated With Abiraterone Without Prednisone

scientific article published on 5 January 2017

Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic Therapies.

scientific article published on 17 December 2015

Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time

scientific article published on 06 February 2019

Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2.

scientific article

Immunotargeted therapy in melanoma: patient, provider preferences, and willingness to pay at an academic cancer center

scientific article published on 01 December 2019

Impact of a genetic counseling requirement prior to genetic testing.

scientific article

Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.

scientific article

Novel and Emerging Strategies in Drug Delivery for Overcoming the Blood–Brain Barrier

scientific article published on December 1, 2009

PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer

scientific article published on 19 September 2018

Panobinostat for the treatment of multiple myeloma: the evidence to date

scientific article

Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online.

scientific article published on 16 October 2017

Pharmacist's attitudes and knowledge of pharmacogenomics and the factors that may predict future engagement

scientific article published on 01 July 2020

Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer

scientific article published on 10 October 2018

Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma

scientific article published in PLoS ONE

Response monitoring, tolerability, and effectiveness of imatinib treatment for chronic myeloid leukemia in a retrospective research database

scientific article published on August 2014

Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma.

scientific article

Targeting Bacteroides in Stool Microbiome and Response to Treatment With First-Line VEGF Tyrosine Kinase Inhibitors in Metastatic Renal-Cell Carcinoma.

scientific article

The pharmacoeconomics of breakthrough cancer pain.

scientific article published on 20 May 2013

Time from definitive therapy to onset of metastatic disease predicts outcomes in men with metastatic hormone sensitive prostate cancer

scientific article published on 13 February 2019

Treatment Patterns and Outcomes in Patients With Hepatocellular Carcinoma Stratified by Stage-Guided Treatment Categories.

scientific article published on August 2015